Revision history of "ASPIRIN (ASA)"

From CRS EMS Guidelines

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

  • curprev 21:19, 3 April 2022‎ Cgabryszek talk contribs‎ 1,584 bytes +1,584‎ Created page with "'''Class''' Platelet inhibitor/Anti-inflammatory '''Pharmacology and Actions''' # ASA inhibits blood clotting. It inhibits the formation of thromboxane A2, a platelet aggregating, vasoconstricting prostaglandin. ASA in low doses, however, inhibits the production of thromboxane A2 in the platelet more than it does the production of prostacyclin in the endothelial cells. # Platelet aggregation has been implicated in the pathogenesis of atherosclerosis contributing to th..." Tag: Visual edit
Retrieved from "https://www.crsguidelines.org/index.php?title=ASPIRIN_(ASA)"